Global RNA Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global RNA Therapeutics market size was valued at US$ million in 2022. With growing demand in downstream market, the RNA Therapeutics is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global RNA Therapeutics market. RNA Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA Therapeutics market.
RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
Key Features:
The report on RNA Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA Therapeutics market. It may include historical data, market segmentation by Type (e.g., mRNA, RNA Interference (RNAi)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA Therapeutics industry. This include advancements in RNA Therapeutics technology, RNA Therapeutics new entrants, RNA Therapeutics new investment, and other innovations that are shaping the future of RNA Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for RNA Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA Therapeutics market.
Market Segmentation:
RNA Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global RNA Therapeutics market size was valued at US$ million in 2022. With growing demand in downstream market, the RNA Therapeutics is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global RNA Therapeutics market. RNA Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA Therapeutics market.
RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
Key Features:
The report on RNA Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA Therapeutics market. It may include historical data, market segmentation by Type (e.g., mRNA, RNA Interference (RNAi)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA Therapeutics industry. This include advancements in RNA Therapeutics technology, RNA Therapeutics new entrants, RNA Therapeutics new investment, and other innovations that are shaping the future of RNA Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for RNA Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA Therapeutics market.
Market Segmentation:
RNA Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- mRNA
- RNA Interference (RNAi)
- Antisense Oligonucleotide (ASO)
- Other
- Hospitals
- Research Institutions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- Alnylam Pharmaceuticals
- Novartis
- Ionis Pharmaceuticals
- Sarepta Therapeutics
- Sanofi
- Pfizer
- Arrowhead Pharmaceuticals
- BioNTech
- Orna Therapeutics
- CRISPR Therapeutics
- Silence Therapeutics
- Astellas Pharma Inc.
- CureVac
- Sirnaomics
- Arcturus Therapeutics
- Arbutus Biopharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Therapeutics Market Size 2018-2029
2.1.2 RNA Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 RNA Therapeutics Segment by Type
2.2.1 mRNA
2.2.2 RNA Interference (RNAi)
2.2.3 Antisense Oligonucleotide (ASO)
2.2.4 Other
2.3 RNA Therapeutics Market Size by Type
2.3.1 RNA Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global RNA Therapeutics Market Size Market Share by Type (2018-2023)
2.4 RNA Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Research Institutions
2.5 RNA Therapeutics Market Size by Application
2.5.1 RNA Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global RNA Therapeutics Market Size Market Share by Application (2018-2023)
3 RNA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 RNA Therapeutics Market Size Market Share by Players
3.1.1 Global RNA Therapeutics Revenue by Players (2018-2023)
3.1.2 Global RNA Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global RNA Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA THERAPEUTICS BY REGIONS
4.1 RNA Therapeutics Market Size by Regions (2018-2023)
4.2 Americas RNA Therapeutics Market Size Growth (2018-2023)
4.3 APAC RNA Therapeutics Market Size Growth (2018-2023)
4.4 Europe RNA Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa RNA Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas RNA Therapeutics Market Size by Country (2018-2023)
5.2 Americas RNA Therapeutics Market Size by Type (2018-2023)
5.3 Americas RNA Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Therapeutics Market Size by Region (2018-2023)
6.2 APAC RNA Therapeutics Market Size by Type (2018-2023)
6.3 APAC RNA Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RNA Therapeutics by Country (2018-2023)
7.2 Europe RNA Therapeutics Market Size by Type (2018-2023)
7.3 Europe RNA Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Therapeutics by Region (2018-2023)
8.2 Middle East & Africa RNA Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa RNA Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RNA THERAPEUTICS MARKET FORECAST
10.1 Global RNA Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global RNA Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas RNA Therapeutics Forecast
10.1.3 APAC RNA Therapeutics Forecast
10.1.4 Europe RNA Therapeutics Forecast
10.1.5 Middle East & Africa RNA Therapeutics Forecast
10.2 Americas RNA Therapeutics Forecast by Country (2024-2029)
10.2.1 United States RNA Therapeutics Market Forecast
10.2.2 Canada RNA Therapeutics Market Forecast
10.2.3 Mexico RNA Therapeutics Market Forecast
10.2.4 Brazil RNA Therapeutics Market Forecast
10.3 APAC RNA Therapeutics Forecast by Region (2024-2029)
10.3.1 China RNA Therapeutics Market Forecast
10.3.2 Japan RNA Therapeutics Market Forecast
10.3.3 Korea RNA Therapeutics Market Forecast
10.3.4 Southeast Asia RNA Therapeutics Market Forecast
10.3.5 India RNA Therapeutics Market Forecast
10.3.6 Australia RNA Therapeutics Market Forecast
10.4 Europe RNA Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany RNA Therapeutics Market Forecast
10.4.2 France RNA Therapeutics Market Forecast
10.4.3 UK RNA Therapeutics Market Forecast
10.4.4 Italy RNA Therapeutics Market Forecast
10.4.5 Russia RNA Therapeutics Market Forecast
10.5 Middle East & Africa RNA Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt RNA Therapeutics Market Forecast
10.5.2 South Africa RNA Therapeutics Market Forecast
10.5.3 Israel RNA Therapeutics Market Forecast
10.5.4 Turkey RNA Therapeutics Market Forecast
10.5.5 GCC Countries RNA Therapeutics Market Forecast
10.6 Global RNA Therapeutics Forecast by Type (2024-2029)
10.7 Global RNA Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna RNA Therapeutics Product Offered
11.1.3 Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Moderna Main Business Overview
11.1.5 Moderna Latest Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Information
11.2.2 Alnylam Pharmaceuticals RNA Therapeutics Product Offered
11.2.3 Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Alnylam Pharmaceuticals Main Business Overview
11.2.5 Alnylam Pharmaceuticals Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis RNA Therapeutics Product Offered
11.3.3 Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Information
11.4.2 Ionis Pharmaceuticals RNA Therapeutics Product Offered
11.4.3 Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Ionis Pharmaceuticals Main Business Overview
11.4.5 Ionis Pharmaceuticals Latest Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Information
11.5.2 Sarepta Therapeutics RNA Therapeutics Product Offered
11.5.3 Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sarepta Therapeutics Main Business Overview
11.5.5 Sarepta Therapeutics Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi RNA Therapeutics Product Offered
11.6.3 Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer RNA Therapeutics Product Offered
11.7.3 Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Arrowhead Pharmaceuticals
11.8.1 Arrowhead Pharmaceuticals Company Information
11.8.2 Arrowhead Pharmaceuticals RNA Therapeutics Product Offered
11.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Arrowhead Pharmaceuticals Main Business Overview
11.8.5 Arrowhead Pharmaceuticals Latest Developments
11.9 BioNTech
11.9.1 BioNTech Company Information
11.9.2 BioNTech RNA Therapeutics Product Offered
11.9.3 BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioNTech Main Business Overview
11.9.5 BioNTech Latest Developments
11.10 Orna Therapeutics
11.10.1 Orna Therapeutics Company Information
11.10.2 Orna Therapeutics RNA Therapeutics Product Offered
11.10.3 Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Orna Therapeutics Main Business Overview
11.10.5 Orna Therapeutics Latest Developments
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Information
11.11.2 CRISPR Therapeutics RNA Therapeutics Product Offered
11.11.3 CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 CRISPR Therapeutics Main Business Overview
11.11.5 CRISPR Therapeutics Latest Developments
11.12 Silence Therapeutics
11.12.1 Silence Therapeutics Company Information
11.12.2 Silence Therapeutics RNA Therapeutics Product Offered
11.12.3 Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Silence Therapeutics Main Business Overview
11.12.5 Silence Therapeutics Latest Developments
11.13 Astellas Pharma Inc.
11.13.1 Astellas Pharma Inc. Company Information
11.13.2 Astellas Pharma Inc. RNA Therapeutics Product Offered
11.13.3 Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Astellas Pharma Inc. Main Business Overview
11.13.5 Astellas Pharma Inc. Latest Developments
11.14 CureVac
11.14.1 CureVac Company Information
11.14.2 CureVac RNA Therapeutics Product Offered
11.14.3 CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CureVac Main Business Overview
11.14.5 CureVac Latest Developments
11.15 Sirnaomics
11.15.1 Sirnaomics Company Information
11.15.2 Sirnaomics RNA Therapeutics Product Offered
11.15.3 Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sirnaomics Main Business Overview
11.15.5 Sirnaomics Latest Developments
11.16 Arcturus Therapeutics
11.16.1 Arcturus Therapeutics Company Information
11.16.2 Arcturus Therapeutics RNA Therapeutics Product Offered
11.16.3 Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Arcturus Therapeutics Main Business Overview
11.16.5 Arcturus Therapeutics Latest Developments
11.17 Arbutus Biopharma
11.17.1 Arbutus Biopharma Company Information
11.17.2 Arbutus Biopharma RNA Therapeutics Product Offered
11.17.3 Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Arbutus Biopharma Main Business Overview
11.17.5 Arbutus Biopharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Therapeutics Market Size 2018-2029
2.1.2 RNA Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 RNA Therapeutics Segment by Type
2.2.1 mRNA
2.2.2 RNA Interference (RNAi)
2.2.3 Antisense Oligonucleotide (ASO)
2.2.4 Other
2.3 RNA Therapeutics Market Size by Type
2.3.1 RNA Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global RNA Therapeutics Market Size Market Share by Type (2018-2023)
2.4 RNA Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Research Institutions
2.5 RNA Therapeutics Market Size by Application
2.5.1 RNA Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global RNA Therapeutics Market Size Market Share by Application (2018-2023)
3 RNA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 RNA Therapeutics Market Size Market Share by Players
3.1.1 Global RNA Therapeutics Revenue by Players (2018-2023)
3.1.2 Global RNA Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global RNA Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA THERAPEUTICS BY REGIONS
4.1 RNA Therapeutics Market Size by Regions (2018-2023)
4.2 Americas RNA Therapeutics Market Size Growth (2018-2023)
4.3 APAC RNA Therapeutics Market Size Growth (2018-2023)
4.4 Europe RNA Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa RNA Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas RNA Therapeutics Market Size by Country (2018-2023)
5.2 Americas RNA Therapeutics Market Size by Type (2018-2023)
5.3 Americas RNA Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Therapeutics Market Size by Region (2018-2023)
6.2 APAC RNA Therapeutics Market Size by Type (2018-2023)
6.3 APAC RNA Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RNA Therapeutics by Country (2018-2023)
7.2 Europe RNA Therapeutics Market Size by Type (2018-2023)
7.3 Europe RNA Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Therapeutics by Region (2018-2023)
8.2 Middle East & Africa RNA Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa RNA Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RNA THERAPEUTICS MARKET FORECAST
10.1 Global RNA Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global RNA Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas RNA Therapeutics Forecast
10.1.3 APAC RNA Therapeutics Forecast
10.1.4 Europe RNA Therapeutics Forecast
10.1.5 Middle East & Africa RNA Therapeutics Forecast
10.2 Americas RNA Therapeutics Forecast by Country (2024-2029)
10.2.1 United States RNA Therapeutics Market Forecast
10.2.2 Canada RNA Therapeutics Market Forecast
10.2.3 Mexico RNA Therapeutics Market Forecast
10.2.4 Brazil RNA Therapeutics Market Forecast
10.3 APAC RNA Therapeutics Forecast by Region (2024-2029)
10.3.1 China RNA Therapeutics Market Forecast
10.3.2 Japan RNA Therapeutics Market Forecast
10.3.3 Korea RNA Therapeutics Market Forecast
10.3.4 Southeast Asia RNA Therapeutics Market Forecast
10.3.5 India RNA Therapeutics Market Forecast
10.3.6 Australia RNA Therapeutics Market Forecast
10.4 Europe RNA Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany RNA Therapeutics Market Forecast
10.4.2 France RNA Therapeutics Market Forecast
10.4.3 UK RNA Therapeutics Market Forecast
10.4.4 Italy RNA Therapeutics Market Forecast
10.4.5 Russia RNA Therapeutics Market Forecast
10.5 Middle East & Africa RNA Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt RNA Therapeutics Market Forecast
10.5.2 South Africa RNA Therapeutics Market Forecast
10.5.3 Israel RNA Therapeutics Market Forecast
10.5.4 Turkey RNA Therapeutics Market Forecast
10.5.5 GCC Countries RNA Therapeutics Market Forecast
10.6 Global RNA Therapeutics Forecast by Type (2024-2029)
10.7 Global RNA Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna RNA Therapeutics Product Offered
11.1.3 Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Moderna Main Business Overview
11.1.5 Moderna Latest Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Information
11.2.2 Alnylam Pharmaceuticals RNA Therapeutics Product Offered
11.2.3 Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Alnylam Pharmaceuticals Main Business Overview
11.2.5 Alnylam Pharmaceuticals Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis RNA Therapeutics Product Offered
11.3.3 Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Information
11.4.2 Ionis Pharmaceuticals RNA Therapeutics Product Offered
11.4.3 Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Ionis Pharmaceuticals Main Business Overview
11.4.5 Ionis Pharmaceuticals Latest Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Information
11.5.2 Sarepta Therapeutics RNA Therapeutics Product Offered
11.5.3 Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sarepta Therapeutics Main Business Overview
11.5.5 Sarepta Therapeutics Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi RNA Therapeutics Product Offered
11.6.3 Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer RNA Therapeutics Product Offered
11.7.3 Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Arrowhead Pharmaceuticals
11.8.1 Arrowhead Pharmaceuticals Company Information
11.8.2 Arrowhead Pharmaceuticals RNA Therapeutics Product Offered
11.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Arrowhead Pharmaceuticals Main Business Overview
11.8.5 Arrowhead Pharmaceuticals Latest Developments
11.9 BioNTech
11.9.1 BioNTech Company Information
11.9.2 BioNTech RNA Therapeutics Product Offered
11.9.3 BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioNTech Main Business Overview
11.9.5 BioNTech Latest Developments
11.10 Orna Therapeutics
11.10.1 Orna Therapeutics Company Information
11.10.2 Orna Therapeutics RNA Therapeutics Product Offered
11.10.3 Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Orna Therapeutics Main Business Overview
11.10.5 Orna Therapeutics Latest Developments
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Information
11.11.2 CRISPR Therapeutics RNA Therapeutics Product Offered
11.11.3 CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 CRISPR Therapeutics Main Business Overview
11.11.5 CRISPR Therapeutics Latest Developments
11.12 Silence Therapeutics
11.12.1 Silence Therapeutics Company Information
11.12.2 Silence Therapeutics RNA Therapeutics Product Offered
11.12.3 Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Silence Therapeutics Main Business Overview
11.12.5 Silence Therapeutics Latest Developments
11.13 Astellas Pharma Inc.
11.13.1 Astellas Pharma Inc. Company Information
11.13.2 Astellas Pharma Inc. RNA Therapeutics Product Offered
11.13.3 Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Astellas Pharma Inc. Main Business Overview
11.13.5 Astellas Pharma Inc. Latest Developments
11.14 CureVac
11.14.1 CureVac Company Information
11.14.2 CureVac RNA Therapeutics Product Offered
11.14.3 CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CureVac Main Business Overview
11.14.5 CureVac Latest Developments
11.15 Sirnaomics
11.15.1 Sirnaomics Company Information
11.15.2 Sirnaomics RNA Therapeutics Product Offered
11.15.3 Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sirnaomics Main Business Overview
11.15.5 Sirnaomics Latest Developments
11.16 Arcturus Therapeutics
11.16.1 Arcturus Therapeutics Company Information
11.16.2 Arcturus Therapeutics RNA Therapeutics Product Offered
11.16.3 Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Arcturus Therapeutics Main Business Overview
11.16.5 Arcturus Therapeutics Latest Developments
11.17 Arbutus Biopharma
11.17.1 Arbutus Biopharma Company Information
11.17.2 Arbutus Biopharma RNA Therapeutics Product Offered
11.17.3 Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Arbutus Biopharma Main Business Overview
11.17.5 Arbutus Biopharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. RNA Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of mRNA
Table 3. Major Players of RNA Interference (RNAi)
Table 4. Major Players of Antisense Oligonucleotide (ASO)
Table 5. Major Players of Other
Table 6. RNA Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 9. RNA Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 12. Global RNA Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global RNA Therapeutics Revenue Market Share by Player (2018-2023)
Table 14. RNA Therapeutics Key Players Head office and Products Offered
Table 15. RNA Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNA Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global RNA Therapeutics Market Size Market Share by Regions (2018-2023)
Table 20. Global RNA Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global RNA Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas RNA Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas RNA Therapeutics Market Size Market Share by Country (2018-2023)
Table 24. Americas RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 26. Americas RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 28. APAC RNA Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC RNA Therapeutics Market Size Market Share by Region (2018-2023)
Table 30. APAC RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 32. APAC RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 34. Europe RNA Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe RNA Therapeutics Market Size Market Share by Country (2018-2023)
Table 36. Europe RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 38. Europe RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa RNA Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa RNA Therapeutics Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of RNA Therapeutics
Table 47. Key Market Challenges & Risks of RNA Therapeutics
Table 48. Key Industry Trends of RNA Therapeutics
Table 49. Global RNA Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global RNA Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global RNA Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global RNA Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Moderna Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 54. Moderna RNA Therapeutics Product Offered
Table 55. Moderna RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Moderna Main Business
Table 57. Moderna Latest Developments
Table 58. Alnylam Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 59. Alnylam Pharmaceuticals RNA Therapeutics Product Offered
Table 60. Alnylam Pharmaceuticals Main Business
Table 61. Alnylam Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Alnylam Pharmaceuticals Latest Developments
Table 63. Novartis Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 64. Novartis RNA Therapeutics Product Offered
Table 65. Novartis Main Business
Table 66. Novartis RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Novartis Latest Developments
Table 68. Ionis Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 69. Ionis Pharmaceuticals RNA Therapeutics Product Offered
Table 70. Ionis Pharmaceuticals Main Business
Table 71. Ionis Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Ionis Pharmaceuticals Latest Developments
Table 73. Sarepta Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 74. Sarepta Therapeutics RNA Therapeutics Product Offered
Table 75. Sarepta Therapeutics Main Business
Table 76. Sarepta Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Sarepta Therapeutics Latest Developments
Table 78. Sanofi Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 79. Sanofi RNA Therapeutics Product Offered
Table 80. Sanofi Main Business
Table 81. Sanofi RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sanofi Latest Developments
Table 83. Pfizer Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 84. Pfizer RNA Therapeutics Product Offered
Table 85. Pfizer Main Business
Table 86. Pfizer RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Pfizer Latest Developments
Table 88. Arrowhead Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 89. Arrowhead Pharmaceuticals RNA Therapeutics Product Offered
Table 90. Arrowhead Pharmaceuticals Main Business
Table 91. Arrowhead Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Arrowhead Pharmaceuticals Latest Developments
Table 93. BioNTech Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 94. BioNTech RNA Therapeutics Product Offered
Table 95. BioNTech Main Business
Table 96. BioNTech RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. BioNTech Latest Developments
Table 98. Orna Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 99. Orna Therapeutics RNA Therapeutics Product Offered
Table 100. Orna Therapeutics Main Business
Table 101. Orna Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Orna Therapeutics Latest Developments
Table 103. CRISPR Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 104. CRISPR Therapeutics RNA Therapeutics Product Offered
Table 105. CRISPR Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. CRISPR Therapeutics Main Business
Table 107. CRISPR Therapeutics Latest Developments
Table 108. Silence Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 109. Silence Therapeutics RNA Therapeutics Product Offered
Table 110. Silence Therapeutics Main Business
Table 111. Silence Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Silence Therapeutics Latest Developments
Table 113. Astellas Pharma Inc. Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 114. Astellas Pharma Inc. RNA Therapeutics Product Offered
Table 115. Astellas Pharma Inc. Main Business
Table 116. Astellas Pharma Inc. RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Astellas Pharma Inc. Latest Developments
Table 118. CureVac Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 119. CureVac RNA Therapeutics Product Offered
Table 120. CureVac Main Business
Table 121. CureVac RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. CureVac Latest Developments
Table 123. Sirnaomics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 124. Sirnaomics RNA Therapeutics Product Offered
Table 125. Sirnaomics Main Business
Table 126. Sirnaomics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Sirnaomics Latest Developments
Table 128. Arcturus Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 129. Arcturus Therapeutics RNA Therapeutics Product Offered
Table 130. Arcturus Therapeutics Main Business
Table 131. Arcturus Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Arcturus Therapeutics Latest Developments
Table 133. Arbutus Biopharma Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 134. Arbutus Biopharma RNA Therapeutics Product Offered
Table 135. Arbutus Biopharma Main Business
Table 136. Arbutus Biopharma RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Arbutus Biopharma Latest Developments
Table 1. RNA Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of mRNA
Table 3. Major Players of RNA Interference (RNAi)
Table 4. Major Players of Antisense Oligonucleotide (ASO)
Table 5. Major Players of Other
Table 6. RNA Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 9. RNA Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 12. Global RNA Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global RNA Therapeutics Revenue Market Share by Player (2018-2023)
Table 14. RNA Therapeutics Key Players Head office and Products Offered
Table 15. RNA Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNA Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global RNA Therapeutics Market Size Market Share by Regions (2018-2023)
Table 20. Global RNA Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global RNA Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas RNA Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas RNA Therapeutics Market Size Market Share by Country (2018-2023)
Table 24. Americas RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 26. Americas RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 28. APAC RNA Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC RNA Therapeutics Market Size Market Share by Region (2018-2023)
Table 30. APAC RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 32. APAC RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 34. Europe RNA Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe RNA Therapeutics Market Size Market Share by Country (2018-2023)
Table 36. Europe RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 38. Europe RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa RNA Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa RNA Therapeutics Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa RNA Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa RNA Therapeutics Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa RNA Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa RNA Therapeutics Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of RNA Therapeutics
Table 47. Key Market Challenges & Risks of RNA Therapeutics
Table 48. Key Industry Trends of RNA Therapeutics
Table 49. Global RNA Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global RNA Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global RNA Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global RNA Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Moderna Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 54. Moderna RNA Therapeutics Product Offered
Table 55. Moderna RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Moderna Main Business
Table 57. Moderna Latest Developments
Table 58. Alnylam Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 59. Alnylam Pharmaceuticals RNA Therapeutics Product Offered
Table 60. Alnylam Pharmaceuticals Main Business
Table 61. Alnylam Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Alnylam Pharmaceuticals Latest Developments
Table 63. Novartis Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 64. Novartis RNA Therapeutics Product Offered
Table 65. Novartis Main Business
Table 66. Novartis RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Novartis Latest Developments
Table 68. Ionis Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 69. Ionis Pharmaceuticals RNA Therapeutics Product Offered
Table 70. Ionis Pharmaceuticals Main Business
Table 71. Ionis Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Ionis Pharmaceuticals Latest Developments
Table 73. Sarepta Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 74. Sarepta Therapeutics RNA Therapeutics Product Offered
Table 75. Sarepta Therapeutics Main Business
Table 76. Sarepta Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Sarepta Therapeutics Latest Developments
Table 78. Sanofi Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 79. Sanofi RNA Therapeutics Product Offered
Table 80. Sanofi Main Business
Table 81. Sanofi RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sanofi Latest Developments
Table 83. Pfizer Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 84. Pfizer RNA Therapeutics Product Offered
Table 85. Pfizer Main Business
Table 86. Pfizer RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Pfizer Latest Developments
Table 88. Arrowhead Pharmaceuticals Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 89. Arrowhead Pharmaceuticals RNA Therapeutics Product Offered
Table 90. Arrowhead Pharmaceuticals Main Business
Table 91. Arrowhead Pharmaceuticals RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Arrowhead Pharmaceuticals Latest Developments
Table 93. BioNTech Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 94. BioNTech RNA Therapeutics Product Offered
Table 95. BioNTech Main Business
Table 96. BioNTech RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. BioNTech Latest Developments
Table 98. Orna Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 99. Orna Therapeutics RNA Therapeutics Product Offered
Table 100. Orna Therapeutics Main Business
Table 101. Orna Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Orna Therapeutics Latest Developments
Table 103. CRISPR Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 104. CRISPR Therapeutics RNA Therapeutics Product Offered
Table 105. CRISPR Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. CRISPR Therapeutics Main Business
Table 107. CRISPR Therapeutics Latest Developments
Table 108. Silence Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 109. Silence Therapeutics RNA Therapeutics Product Offered
Table 110. Silence Therapeutics Main Business
Table 111. Silence Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Silence Therapeutics Latest Developments
Table 113. Astellas Pharma Inc. Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 114. Astellas Pharma Inc. RNA Therapeutics Product Offered
Table 115. Astellas Pharma Inc. Main Business
Table 116. Astellas Pharma Inc. RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Astellas Pharma Inc. Latest Developments
Table 118. CureVac Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 119. CureVac RNA Therapeutics Product Offered
Table 120. CureVac Main Business
Table 121. CureVac RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. CureVac Latest Developments
Table 123. Sirnaomics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 124. Sirnaomics RNA Therapeutics Product Offered
Table 125. Sirnaomics Main Business
Table 126. Sirnaomics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Sirnaomics Latest Developments
Table 128. Arcturus Therapeutics Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 129. Arcturus Therapeutics RNA Therapeutics Product Offered
Table 130. Arcturus Therapeutics Main Business
Table 131. Arcturus Therapeutics RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Arcturus Therapeutics Latest Developments
Table 133. Arbutus Biopharma Details, Company Type, RNA Therapeutics Area Served and Its Competitors
Table 134. Arbutus Biopharma RNA Therapeutics Product Offered
Table 135. Arbutus Biopharma Main Business
Table 136. Arbutus Biopharma RNA Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Arbutus Biopharma Latest Developments
LIST OF FIGURES
Figure 1. RNA Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. RNA Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. RNA Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. RNA Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global RNA Therapeutics Market Size Market Share by Type in 2022
Figure 10. RNA Therapeutics in Hospitals
Figure 11. Global RNA Therapeutics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. RNA Therapeutics in Research Institutions
Figure 13. Global RNA Therapeutics Market: Research Institutions (2018-2023) & ($ Millions)
Figure 14. Global RNA Therapeutics Market Size Market Share by Application in 2022
Figure 15. Global RNA Therapeutics Revenue Market Share by Player in 2022
Figure 16. Global RNA Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 17. Americas RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 18. APAC RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 19. Europe RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Americas RNA Therapeutics Value Market Share by Country in 2022
Figure 22. United States RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC RNA Therapeutics Market Size Market Share by Region in 2022
Figure 27. APAC RNA Therapeutics Market Size Market Share by Type in 2022
Figure 28. APAC RNA Therapeutics Market Size Market Share by Application in 2022
Figure 29. China RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. India RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe RNA Therapeutics Market Size Market Share by Country in 2022
Figure 36. Europe RNA Therapeutics Market Size Market Share by Type (2018-2023)
Figure 37. Europe RNA Therapeutics Market Size Market Share by Application (2018-2023)
Figure 38. Germany RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. France RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa RNA Therapeutics Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa RNA Therapeutics Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa RNA Therapeutics Market Size Market Share by Application (2018-2023)
Figure 46. Egypt RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 52. APAC RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 53. Europe RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. United States RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Canada RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Mexico RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Brazil RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. China RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Japan RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Korea RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. India RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Australia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Germany RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. France RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. UK RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Italy RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Russia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Spain RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Egypt RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. South Africa RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Israel RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Turkey RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Global RNA Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global RNA Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. RNA Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. RNA Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. RNA Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. RNA Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global RNA Therapeutics Market Size Market Share by Type in 2022
Figure 10. RNA Therapeutics in Hospitals
Figure 11. Global RNA Therapeutics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. RNA Therapeutics in Research Institutions
Figure 13. Global RNA Therapeutics Market: Research Institutions (2018-2023) & ($ Millions)
Figure 14. Global RNA Therapeutics Market Size Market Share by Application in 2022
Figure 15. Global RNA Therapeutics Revenue Market Share by Player in 2022
Figure 16. Global RNA Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 17. Americas RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 18. APAC RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 19. Europe RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa RNA Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Americas RNA Therapeutics Value Market Share by Country in 2022
Figure 22. United States RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC RNA Therapeutics Market Size Market Share by Region in 2022
Figure 27. APAC RNA Therapeutics Market Size Market Share by Type in 2022
Figure 28. APAC RNA Therapeutics Market Size Market Share by Application in 2022
Figure 29. China RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. India RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe RNA Therapeutics Market Size Market Share by Country in 2022
Figure 36. Europe RNA Therapeutics Market Size Market Share by Type (2018-2023)
Figure 37. Europe RNA Therapeutics Market Size Market Share by Application (2018-2023)
Figure 38. Germany RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. France RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa RNA Therapeutics Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa RNA Therapeutics Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa RNA Therapeutics Market Size Market Share by Application (2018-2023)
Figure 46. Egypt RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country RNA Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 52. APAC RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 53. Europe RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. United States RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Canada RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Mexico RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Brazil RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. China RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Japan RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Korea RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. India RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Australia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Germany RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. France RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. UK RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Italy RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Russia RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Spain RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Egypt RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. South Africa RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Israel RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Turkey RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries RNA Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Global RNA Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global RNA Therapeutics Market Size Market Share Forecast by Application (2024-2029)
